Open AccessAngiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Author(s) -
Duska Dragun,
Dominik N. Müller,
Jan Hinrich Bräsen,
Lutz Fritsche,
Meliieminen-Kelhä,
Ralf Dechend,
Ulrich Kintscher,
Birgit Rudolph,
Johan Hoebeke,
Diana Eckert,
István Mazák,
Ralph Plehm,
Constanze Schönemann,
Thomas Unger,
Klemens Budde,
HansHellmut Neumayer,
Friedrich C. Luft,
Gerd Wallukat
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa035717
Subject(s) - angiotensin ii receptor type 1 , medicine , angiotensin ii , losartan , antibody , receptor , immunology , endocrinology
Antibodies against HLA antigens cause refractory allograft rejection with vasculopathy in some, but not all, patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom